A Phase 1 Study of JNJ-79032421 Targeting Mesothelin for Advanced Stage Solid Tumors
Phase 1 other active
Quick answer
A Phase 1 Study of JNJ-79032421 Targeting Mesothelin for Advanced Stage Solid Tumors for Advanced Stage Solid Tumors is a Phase 1 program (other) at Janssen-Cilag International N.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Janssen-Cilag International N.V.
- Indication
- Advanced Stage Solid Tumors
- Phase
- Phase 1
- Modality
- other
- Status
- active